MSCI rejig may bring ₹30,214 crore into Indian equities by August 31
Synopsis
A JM Financial report projects ₹30,214 crore in passive inflows into Indian equities from the upcoming MSCI India Standard Index rejig, with Laurus Labs and Biocon the likeliest upgrades. With $18 billion in FII outflows already weighing on India in 2025, this rebalancing could be a meaningful — if selective — reversal of that trend.
Key Takeaways
MSCI is expected to announce its India Standard Index rebalancing on 12 August , effective 31 August .
The rejig is projected to attract passive inflows of ₹30,214 crore into Indian equities, per JM Financial .
Laurus Labs (potential inflow: ₹4,683 crore ) and Biocon ( ₹2,785 crore ) are top contenders for upgrade from the Small Cap Index.
Apar Industries and Uno Minda have medium upgrade probability, with potential inflows of ₹2,464 crore and ₹1,936 crore respectively.
FII outflows of nearly $18 billion in 2025 have left India underweight in many global portfolios, creating room for selective re-entry.
Around 75% of the MSCI Emerging Markets index is concentrated in China , India , South Korea , and Taiwan .
The upcoming rebalancing of the MSCI India Standard Index, expected to be announced on 12 August and take effect from 31 August, is projected to channel passive inflows of approximately ₹30,214 crore into Indian equities, according to a report by JM Financial. The review could mark a significant shift in how global passive funds and ETFs allocate capital to Indian stocks.
Top Contenders for Upgrade
Laurus Labs and Biocon are emerging as the strongest candidates for promotion from the MSCI India Small Cap Index to the MSCI India Standard Index, the brokerage said, assigning both a high probability of inclusion. Laurus Labs could attract inflows of around ₹4,683 crore, while Biocon may see nearly ₹2,785 crore flow in, according to JM Financial's estimates.
Apar Industries and Uno Minda have been assigned medium probabilities of upgrade, with potential inflows of ₹2,464 crore and ₹1,936 crore, respectively, the report added.
Why This Rebalancing Matters
MSCI index reviews are closely tracked by institutional investors because changes in index composition directly trigger buying and selling by passive funds that replicate these benchmarks. Analysts noted that the previous MSCI rebalancing likely amplified volatility during the final 30 minutes of trading on the last trading day of May, contributing to a steep late-session decline — a pattern markets are already bracing for ahead of the August 31 implementation date.
This comes amid a broader context of sustained foreign institutional investor (FII) outflows: India has seen nearly $18 billion exit in 2025, leaving the country underweight in many global portfolios. Analysts argue this creates meaningful scope for selective re-entry if emerging market sentiment turns.
India's Position in the MSCI Emerging Markets Index
India is classified as an emerging market under MSCI's market classification framework, alongside South Korea, Taiwan, China, and Mexico, among 24 such markets. Notably, around 75 per cent of the MSCI Emerging Markets index is concentrated in just four markets — China, India, South Korea, and Taiwan — meaning any shift in India's index weight carries outsized implications for global fund flows.
What to Watch Next
The official MSCI announcement on 12 August will confirm which stocks are added or removed. Traders and fund managers are expected to begin positioning ahead of the 31 August implementation, with heightened volatility likely in the stocks under consideration. If FII sentiment toward emerging markets improves in parallel, the actual inflows could exceed current estimates.
Point of View
214 crore inflow sounds large, but it is overwhelmingly passive — mechanical, index-driven money that arrives and departs with the next rebalancing. The more telling figure is the $18 billion in FII outflows India has absorbed in 2025 alone; a single index event will not reverse that structural underweight. Laurus Labs and Biocon would benefit disproportionately if upgraded, but their long-term re-rating depends on earnings delivery, not index mechanics. The real question is whether improved emerging market sentiment — driven by Fed policy or China risk aversion — brings active money back to India alongside the passive wave.
NationPress
22 Jun 2026
Frequently Asked Questions
What is the MSCI India Standard Index rebalancing?
The MSCI India Standard Index rebalancing is a periodic review in which MSCI adds or removes stocks from its benchmark Indian equity index. The next announcement is expected on 12 August, with changes taking effect from 31 August, and is projected to trigger passive inflows of ₹30,214 crore into Indian equities.
Which stocks are most likely to be added to the MSCI India Standard Index?
Laurus Labs and Biocon are considered the strongest candidates for upgrade from the MSCI India Small Cap Index to the Standard Index, according to JM Financial. Apar Industries and Uno Minda have been assigned medium probabilities of inclusion.
How much inflow could Laurus Labs and Biocon attract?
Laurus Labs could see inflows of approximately ₹4,683 crore, while Biocon may attract nearly ₹2,785 crore if both are upgraded to the MSCI India Standard Index, as estimated by JM Financial.
Why are FII outflows relevant to this MSCI rebalancing?
FII outflows of nearly $18 billion in 2025 have left India underweight in many global portfolios. If emerging market sentiment improves alongside the MSCI rejig, analysts say there is scope for selective inflows beyond just the passive, index-driven component.
How does India fit into the broader MSCI Emerging Markets index?
India is one of 24 countries classified as an emerging market by MSCI. Around 75 per cent of the MSCI Emerging Markets index is concentrated in just four markets — China, India, South Korea, and Taiwan — making any change in India's index weight significant for global fund flows.
